Aureus Asset Management LLC cut its stake in Danaher Co. (NYSE:DHR) by 2.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 35,013 shares of the conglomerate’s stock after selling 1,049 shares during the quarter. Aureus Asset Management LLC’s holdings in Danaher were worth $4,622,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently modified their holdings of the company. CX Institutional increased its stake in shares of Danaher by 188.7% during the first quarter. CX Institutional now owns 205 shares of the conglomerate’s stock valued at $27,000 after buying an additional 134 shares during the period. Laurel Wealth Advisors LLC purchased a new position in shares of Danaher during the fourth quarter valued at $27,000. Lenox Wealth Management Inc. purchased a new position in shares of Danaher during the first quarter valued at $40,000. Hanson McClain Inc. increased its stake in shares of Danaher by 852.9% during the fourth quarter. Hanson McClain Inc. now owns 324 shares of the conglomerate’s stock valued at $33,000 after buying an additional 290 shares during the period. Finally, Executive Wealth Management LLC purchased a new position in shares of Danaher during the fourth quarter valued at $39,000. Institutional investors own 78.93% of the company’s stock.
DHR opened at $138.77 on Thursday. Danaher Co. has a 1 year low of $94.59 and a 1 year high of $139.48. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.74 and a current ratio of 2.18. The stock has a market capitalization of $98.46 billion, a price-to-earnings ratio of 30.70, a P/E/G ratio of 2.66 and a beta of 0.95.
Danaher (NYSE:DHR) last issued its quarterly earnings results on Thursday, April 18th. The conglomerate reported $1.07 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.06. The business had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.80 billion. Danaher had a return on equity of 11.61% and a net margin of 12.04%. The company’s quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter last year, the company earned $0.99 earnings per share. Sell-side analysts predict that Danaher Co. will post 4.77 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.49%. The ex-dividend date is Thursday, June 27th. Danaher’s dividend payout ratio is presently 15.04%.
In other Danaher news, Director Alan G. Spoon sold 1,913 shares of the firm’s stock in a transaction dated Wednesday, April 24th. The stock was sold at an average price of $129.52, for a total value of $247,771.76. Following the completion of the sale, the director now owns 86,863 shares of the company’s stock, valued at $11,250,495.76. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Thomas Patrick Joyce, Jr. sold 183,878 shares of the firm’s stock in a transaction dated Monday, April 29th. The stock was sold at an average price of $131.30, for a total value of $24,143,181.40. Following the completion of the sale, the chief executive officer now directly owns 302,377 shares of the company’s stock, valued at approximately $39,702,100.10. The disclosure for this sale can be found here. In the last three months, insiders sold 453,448 shares of company stock valued at $59,724,640. Corporate insiders own 11.40% of the company’s stock.
Several equities analysts have recently commented on DHR shares. Zacks Investment Research lowered Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, April 23rd. Deutsche Bank raised their price target on Danaher to $130.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. Jefferies Financial Group lifted their target price on Danaher to $140.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. UBS Group lifted their target price on Danaher from $125.00 to $144.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $141.00 target price (up previously from $138.00) on shares of Danaher in a research note on Wednesday, April 17th. Three analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $133.00.
WARNING: “Aureus Asset Management LLC Has $4.62 Million Position in Danaher Co. (NYSE:DHR)” was first posted by American Banking News and is the property of of American Banking News. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this news story can be read at https://www.americanbankingnews.com/2019/06/13/aureus-asset-management-llc-has-4-62-million-position-in-danaher-co-nysedhr.html.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Featured Article: What is a growth and income fund?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.